Immortal mast cell lines, such as RBL-2H3 and HMC-1 cells, are commonly utilized to investigate the function of mast cells. However, they are tumor cells carrying a gain-of-function mutation of Kit. We established an immortal mast cell line without Kit mutation, NCL-2, derived from NC mouse bone marrow. NCL-2 cells could be maintained without additional growth factors and thus could respond to exogenous growth signals. Moreover, NCL-2 cells expressed FceRI and KIT, and release histamine and LTB 4 in response to antigen stimulation. This cell line could be a useful tool to analyze proliferation, differentiation, and function of normal mast cells.
Introduction
Mast cells play a pivotal role in type I hypersensitivity reactions via the high affinity IgE receptors (FceRI) and antigen-specific IgE. The crosslinking of FceRI leads to the activation of numerous signaling molecules, SYK, LAT, PLCc, PKC, and finally results in degranulation, and arachidonic acid and cytokine production [1, 2] . These mediators are involved in the pathogenesis of allergic disorders, such as urticaria, atopic dermatitis (AD), allergic rhinitis, and allergic asthma [2] .
Previous studies on the function of mast cells, especially on degranulation and on signaling pathways mediated by FceRI crosslinking, have been conducted mostly by the use of RBL-2H3 cells [3] . RBL-2H3 cells carry a gain-of-function mutation of Kit [4] thus they do not need exogenous growth factors, such as stem cell factor (SCF) or interleukin (IL)-3. Investigators can maintain the cells without expensive recombinant cytokines but they cannot assess cellular responses against SCF. In addition, it is possible that active KIT protein could affect other signaling pathways such as FceRImediated signaling events [5] . Moreover, Passante et al. reported that RBL-2H3 cells share similarities with basophils and thus they are an imprecise model for mast cell mediator release [6] . MC/9 cells [7] , the rodent mast cells without Kit mutation, need IL-3 to grow. HMC-1 cells, a human mast cell line derived from mast cell leukemia, carry a gain-of-function mutation of Kit and lack surface expression of FceRI [8] . Another human mast cell line, LAD2 cells, responds to SCF but grows slowly even in the presence of 100 ng/ml of recombinant human SCF [9] .
Here we established NCL-2 mast cell line without a gain-offunction of Kit mutation, which respond to SCF and IL-3, and release various chemical mediators against several stimuli including crosslinking of FceRI.
Experiments for Laboratory Animal Science Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University.
Cells
The bone marrow-derived mast cells (BMMC) from 6 weeks old male mice were generated as previously described [10] . Briefly, bone marrow cells were suspended at a density of 1 Â 10 6 cells/ ml in Minimum Essential Medium a (MEMa) (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal calf-serum (FCS), 50 lM 2-mercaptoethanol, 2 mM L-glutamine, antibiotics (complete MEMa), and 5 ng/ml IL-3. The cells were cultured for 4 weeks, replacing half of the existing medium with fresh medium once a week. After 4 weeks, more than 98% of non-adherent cells were stained positively by alcian blue. The BMMC were subcultured about 100 times by 50-fold dilutions in the presence of IL-3. Subsequently, the cells were subcultured another 80 times by 100-fold dilutions without IL-3, and then a single clone (NCL-2) that grew without IL-3 was obtained by limiting dilution. P815 murine mastocytoma cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM, Invitrogen) supplemented with 10% FCS and antibiotics.
Release of histamine and LTB 4
NCL-2 cells were incubated in complete MEMa supplemented with 0.5 lg/ml of DNP-specific IgE overnight. After washing twice with complete MEMa, the cells were stimulated with antigen, ionomycin or ATP at the indicated concentration for 20 min at 37°C. The supernatants were transferred into test tubes and centrifuged at 1500Âg for 5 min at 4°C to eliminate the cell components.
Measurement of histamine
After centrifugation, 200 ll of the supernatants were mixed with equal volumes of 0.5 N perchloric acid to precipitate proteins. Both cell pellets in test tube and residual cell in culture dishes were resolved in 1 ml of 0.25 N perchloric acid to recover all residual histamine. Histamine contents in the samples were measured fluorometrically by using an automated histamine analyzing system (Tosoh Corporation, Osaka, Japan) as described previously [11] . The histamine release was expressed as percentage of total cellular histamine.
Measurement of LTB 4
The amount of leukotriene B 4 (LTB 4 ) in the samples was measured using enzyme-immunoassay kits (Amersham, Buckinghamshire, UK). The measurements were performed according to the manufacture's instruction. The minimum detectable concentration of LTB 4 was 6.0 pg/ml and cross-reactivity for other related substances was less than 0.03%. In order to verify the measurement of LTB 4 by enzyme immunoassay, the supernatant of reaction mixture in one experiment was fractionated by reverse phase high performance liquid chromatography (HPLC) as described before [11] .
Western blot analysis
For detection of IL-3-induced tyrosine phosphorylation of Jak2, 2.5 Â 10 6 NCL-2 cells were stimulated with 100 ng/ml of rmIL-3 for 5 min at 37°C, then quickly centrifuged at 10,000Âg and lysed in the sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, 50 mM DTT, 0.1% bromophenol blue). The proteins were boiled at 95°C for 5 min, centrifuged at 10,000Âg for 10 min, electrophoresed with 5-20% polyacrylamide gel (Atto, Tokyo, Japan), and transferred to a PVDF membrane (Immobilon-P, Merck Millipore, Billerica, MA, USA ) were suspended in 500 ll of PBS(À) and were injected subcutaneously into the left hind flank of Balb/c nude mice. Each tumor size was expressed as a product of a longest diameter and the shortest diameter. Three mice per group were used for the experiment.
DNA sequencing analysis of Kit
A DNA fragment including aspartic acid at codon 814 of Kit was amplified by PCR with sense primer: 5 0 -CCGGAATTCGAGACG TGACTCCTGCCATC-3 0 and antisense primer: 5 0 -CCGCTCGAGCCCAT AGGACCAGACATCAC-3 0 . EcoR I site was adapted to the sense primer and Xho I site was adapted to the antisense primer. EcoR I and Xho I-digested PCR products were ligated into pME18S cut with the same enzymes. DNA sequencing of the plasmids was performed with ABI PRISMTM 310 genetic analyzer (Applied Biosystems). There was no substitution of Asp814 in 26 clones.
RT-PCR analysis of mouse mast cell proteases (mMCPs)
NCL-2 cells (3 Â 10 3 ) were incubated with 100 ng/ml of IL-3 or SCF for 7 days and harvested for the extraction of total RNA with RNeasy Mini Kit (Qiagen, Hilden, Germany). The reverse transcription reaction of RNA was performed with QuantiTect™ reverse transcription kit (Qiagen). PCR analysis of the expression of mMCPs in NCL-2 cells were performed with Tks Gflex™ DNA polymerase (Takara, Shiga, Japan) and the specific primers reported previously [12] .
Results

NCL-2 cells grew without IL-3 or SCF, and expressed FceRI and KIT on their surface
NCL-2 cells grew independently from exogenous growth factors except FCS (Fig. 1A) . The doubling time of NCL-2 cells calculated by exponential growth equation was approximately 30.1 h. On the other hand, P815 cells showed more rapid growth than NCL-2 cells (Fig. 1B) , and the calculated doubling time of P815 cells was approximately 12 h. The surface expression of FceRI and KIT of NCL-2 cells were confirmed by flow cytometric analysis (Fig 1C  and D) .
Degranulation and LTB 4 production of NCL-2 in response to various stimuli
Next, we investigated whether NCL-2 could release chemical mediators in response to various external stimuli including antigens or not. NCL-2 cells were sensitized with anti-DNP IgE and then simulated with various concentrations of DNP-HSA. As shown in Fig. 2A and B, NCL-2 cells secreted histamine and produced LTB 4 in a dose-dependent manner. NCL-2 cells also showed degranulation in response to ionomycin and ATP as well (Fig. 2C and D) .
Tumorigenic property of NCL-2 cells
We then estimated the tumorigenicity of NCL-2 cells in Balb/c nude mice. A mouse lymphoblast-like mastocytoma cell line, P815, showed rapid growth under the skin of nude mice and killed all of them within 2 weeks. Surprisingly, in contrast to P815, NCL-2 did not form tumors within 16 days. Even after inducing visible tumors, NCL-2 cells grew relatively slowly and did not kill mice at up to 40 days (Fig. 3) .
Responses to exogenous growth factors, SCF and IL-3
Furthermore, we investigated whether or not NCL-2 cells could respond to exogenous growth stimuli. NCL-2 cells showed minimal tyrosine phosphorylation of KIT in quiescent state, and then showed robust tyrosine phosphorylation of KIT in response to SCF stimulation (Fig. 4A) . NCL-2 cells also showed tyrosine phosphorylation of JAK2 in response to IL-3 stimulation (Fig. 4B) .
The change in the expression profile of mMCPs by SCF and IL-3
NCL-2 cells were stimulated with 100 ng/ml of IL-3 and SCF for 7 days and the expression profile of mMCPs were studied. As shown in Fig. 5 , NCL-2 cells, which were maintained without growth factors, already expressed mMCP-1, 4, 5, and CPA-3. Furthermore, the stimulation with IL-3 and SCF abolished the expression of mMCP-1, which connective tissue-type mast cells lack to express [13] .
Discussion
In this study, we established an immortal mast cell line, NCL-2, which can grow in the absence of SCF or IL-3. NCL-2 cells express KIT and functional FceRI, and release histamine and LTB 4 in response to antigen stimulation. NCL-2 cells do not have a constitutively active mutation of Kit, thus show slow proliferation in vitro and substantially indolent tumor growth in vivo as compared with P815 mastocytoma cells. Moreover, stimulation with SCF and IL-3 induced tyrosine phosphorylation of KIT and JAK2, respectively. NC mice were established as an inbred strain from Japanese fancy mice by Kondo in 1955. These mice spontaneously develop eczema and elevation of serum IgE similar to human AD in the conventional condition and thus are regarded as a mouse model of AD [14] . We previously reported that BMMC derived from NC/Kuj mice possess higher histamine content, higher adhesive ability, and especially, lack of apoptosis upon growth factor deprivation [15] . We, therefore, suspect that a certain population of BMMC from NC mice may survive without additional growth factors. In the process of establishing NCL-2 cells, we also obtained another immortal cell line, NCL-1, by the same long-term culture of BMMC of NC/Kuj mice. In contrast to NCL-2 cells, NCL-1 cells possessed an active mutation of Kit (D814F) on the single allele (data not shown). The mechanisms of immortality of NCL-2 remained unclear. However, we should keep in mind that BMMC of NC/Kuj has a potential to acquire a de novo active mutation of Kit in long-term cultures.
NCL-2 cells contained alcian-blue positive granules but not safranin-positive granules. Neither IL-3 nor SCF stimulation changed staining properties of granules even when NCL-2 cells were co-cultured with Swiss 3T3 cells for 2 weeks (data not shown). In general, BMMC express mMCP-5 and mCPA-3 without SCF, and express mMCP-4 with SCF [16] . On the other hands, NCL-2 cells express mMCP-4 without SCF stimulation, implying that NCL-2 cells might be partially differentiated mast cells. Furthermore, mucosal type mast cells (MMC) but not connective-tissue type mast cells (CTMC) express mMCP-1 [13] . IL-3 and SCF stimulation abolished the expression of mMCP-1, implying that these cytokines might shift NCL-2 cells towards CTMC-like cells.
In conclusion, NCL-2 cells do not need exogenous growth factors except for FCS to grow and are a useful tool to analyze both physiological and pathological functions of mast cells without the influence of constitutively active KIT. ) were incubated with 100 ng/ml of IL-3 or SCF for 7 days and harvested for RT-PCR analysis of the expression of mMCPs. A representative data of three independent experiments was shown.
